Intravitreal allogeneic mesenchymal stem cells: a non-randomized phase II clinical trial for acute non-arteritic optic neuropathy

BACKGROUND: An effective treatment for acute non-arteritic ischemic optic neuropathy (NA-AION) has not been known or proven yet. Previous studies have suggested a neuroprotective effect of allogeneic bone marrow-derived mesenchymal stem cells. This study aims to report the results of a clinical tria...

Descripción completa

Detalles Bibliográficos
Autores principales: Pastor, Jose C., Pastor-Idoate, Salvador, López-Paniagua, Marina, Para, Marta, Blazquez, Francisco, Murgui, Esther, García, Verónica, Coco-Martín, Rosa M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512539/
https://www.ncbi.nlm.nih.gov/pubmed/37735668
http://dx.doi.org/10.1186/s13287-023-03500-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512539/
https://www.ncbi.nlm.nih.gov/pubmed/37735668
http://dx.doi.org/10.1186/s13287-023-03500-7

Ejemplares similares